◄ back to all posts
Financial data and stock pages provided by
Fintel.io
Value, Margin Of Safety, & The Art Of Doing Nothing
Sep 21, 2020
◄ back to all posts
LCI: Lannett Co., Inc. Stock
Written by | Jul 6, 2018
Print FriendlySIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 235.69 |
| Enterprise Value ($M) | 859.07 |
| Book Value ($M) | 302.90 |
| Book Value / Share | 7.53 |
| Price / Book | 0.77 |
| NCAV ($M) | -390.45 |
| NCAV / Share | -9.71 |
| Price / NCAV | -0.60 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -0.03 |
| Return on Assets (ROA) | -0.03 |
| Return on Equity (ROE) | -0.10 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 1.40 |
| Current Ratio | 2.06 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 443.21 |
| Assets | 1,136.56 |
| Liabilities | 833.66 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.00 |
| Operating Income | 19.56 |
| Net Income | -33.37 |
| Earnings Per Share Diluted | -0.86 |
| Earnings Per Share Basic | -0.86 |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | 116.01 |
| Cash from Investing | -40.00 |
| Cash from Financing | -40.00 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G | Highbridge Capital Management Llc | 5.01 | ||
| 13G/A | D. E. Shaw & Co, L.p. | 8.50 | 1.09 | |
| 13G | Vanguard Group Inc | 5.85 | 172.86 | |
| 13G | Lsv Asset Management | 5.21 | 0.32 | |
| 13G/A | BlackRock Inc. | 13.00 | 9.69 | |
| 13G | Jpmorgan Chase & Co | 6.80 | ||
| 13G/A | Mintbroker International, Ltd. | 0.00 | -100.00 | |
| 13G/A | Flynn James E | 0.00 | -100.00 | |
| 13G/A | Snow Capital Management Lp | 0.90 | -87.92 | |
| 13G/A | Invesco Ltd. | 2.10 | -59.22 | |
| 13G | Ucb S.a. | 6.40 | ||
| 13G/A | Broadfin Capital, LLC | 3.80 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| Annual Report – 10-K | ||
| Quarterly Report – 10-Q | ||
| LCI / Lannett Co., Inc. 10-Q – Quarterly Report – 10-Q | ||
| our Quarterly Report on Form 10-Q filed on November 7, 2019. | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 18,322 | 230,100 | 7.96 | |
| 39,417 | 276,500 | 14.26 | |
| 58,068 | 376,400 | 15.43 | |
| 40,611 | 367,800 | 11.04 | |
| 68,424 | 504,500 | 13.56 | |
(click for more detail) |
|||
(click for list of largest short owners) |
|||
| Similar Companies | |
|---|---|
| HSP – Hospira | JNJ – Johnson & Johnson |
| KDMN – Kadmon Holdings, Inc. | LLY – Eli Lilly & Co. |
| MNK – Mallinckrodt PLC |
Financial data and stock pages provided by
Fintel.io
2018/07/06
Also Read
